Back
ICU Medical Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Buy
53
ICUI
ICU Medical
Last Price:
172.05
Seasonality Move:
9.93%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.ICU Medical Price Quote
$172.05
-2.76 (-1.58%)
(Updated: November 14, 2024 at 5:55 PM ET)
ICU Medical Key Stats
Buy
53
ICU Medical (ICUI)
is a Buy
Day range:
$174.45 - $196.26
52-week range:
$82.82 - $188.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.87
P/B ratio:
2.13%
Volume:
611.5K
Avg. volume:
215.5K
1-year change:
113.11%
Market cap:
$4.3B
Revenue:
$2.3B
EPS:
$-2.92
How Much Does ICU Medical Make?
-
How Much Are ICU Medical's Sales Annually?
ICUI Revenues are $2.3B -
How Much Profit Does ICU Medical's Make A Year?
ICUI net income is -$29.7M
Is ICU Medical Growing As A Company?
-
What Is ICU Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09% -
What Is ICU Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ICU Medical Stock Price Performance
-
Did ICU Medical Stock Go Up Last Month?
ICU Medical share price went down by -2.19% last month -
Did ICUI's Share Price Rise Over The Last Year?
ICUI share price rose by 113.11% over the past 1 year
What Is ICU Medical 52-Week High & Low?
-
What Is ICU Medical’s 52-Week High Share Price?
ICU Medical has traded as high as $188.53 over the past 52 weeks -
What Is ICU Medical’s 52-Week Low Share Price?
ICU Medical has traded as low as $82.82 over the past 52 weeks
ICU Medical Price To Free Cash Flow
-
Is ICU Medical Stock Overvalued?
ICU Medical is trading at a price to free cash flow ratio of 27.53 -
Is ICU Medical Stock Undervalued?
ICU Medical EV to Free Cash Flow ratio is 36.00 -
What Is ICU Medical’s Price Earnings Growth Ratio?
ICUI PEG ratio is -1.37 -
Is ICU Medical Trading At A Premium To Earnings?
ICU Medical EV to EBIT ratio is 769.06
Is It Risky To Buy ICU Medical?
-
How Much Debt Does ICU Medical Have?
Total long term debt quarterly is $1.6B -
How Much Cash Does ICU Medical Have?
Cash and short term investments quarterly total is $302.6M -
What Is ICU Medical’s Book Value Per Share?
Book value per share is 83.43
Is ICU Medical Cash Flow Positive?
-
What Is ICUI Cash Flow From Operations?
Cash flow from operations (TTM) is $254.2M -
What Is ICU Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$51.5M -
What Is ICU Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$94.7M
ICU Medical Return On Invested Capital
-
Is Management Doing A Good Job?
ICUI return on invested capital is -1.91% -
What Is ICU Medical Return On Assets?
ROA measures how assets are converting to revenues and is -1.62% -
What Is ICUI Return On Equity?
ROE is a measure of profitability and is -3.39%
ICU Medical Earnings Date & Stock Price
-
What Is ICU Medical's Stock Price Today?
A single share of ICUI can be purchased today for 174.81 -
What Is ICU Medical’s Stock Symbol?
ICU Medical trades on the nasdaq under the ticker symbol: ICUI -
When Is ICU Medical’s Next Earnings Date?
The next quarterly earnings date for ICU Medical is scheduled on February 27, 2025 -
When Is ICUI's next ex-dividend date?
ICU Medical's next ex-dividend date is November 15, 2024 -
How To Buy ICU Medical Stock?
You can buy ICU Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ICU Medical Competitors
-
Who Are ICU Medical's Competitors?
Below is a list of companies who compete with ICU Medical or are related in some way:
ICU Medical Dividend Yield
-
What Is ICUI Dividend Yield?
ICU Medical’s dividend yield currently is 0% -
What Is ICU Medical’s Payout Ratio?
ICU Medical’s payout ratio is 0% -
When Did ICU Medical Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is ICU Medical’s Dividend Per Share?
ICU Medical pays a dividend of $0.00 per share
ICU Medical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 56.31% |
| Revenue: | 8.58% | 7.71% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 173.83 |
| Downside from Last Price: | -0.56% |